New crystalline form-M of mitapivat sulfate for treating hemolytic anemia, is characterized by the powder X-ray Diffraction pattern having specific peaks
	LAKSHMI C V; PRADEEP R; RAMPRASAD A K; NAGARAJU C
	2023-07-20
专利权人	MAITHRI DRUGS PRIVATE LTD (MAIT-Non-standard)
申请日期	2023-07-20
专利号	IN202341048804-A
成果简介	NOVELTY - Crystalline form-M of mitapivat sulfate is new, characterized by powder X-ray Diffraction (PXRD) pattern having peaks at 4.1, 4.4, 8.2, 9.8, 10.9, 12.17, 13.4, 14.2, 14.5, 14.9, 15.7, 17.1, 17.4, 17.7, 19.7, 20.2, 20.8, 21.7, 22.8, 24.4, 26.7 and 29.5 ± 0.2° 2θ. USE - Crystalline form-M of mitapivat sulfate for treating hemolytic anemia. No biological data given. ADVANTAGE - None given. DETAILED DESCRIPTION - An INDEPENDENT CLAIM is included for a process for the preparation of crystalline form-M of mitapivat sulfate i.e. (4-(4-(cyclopropylmethyl)piperazine-l-carbonyl) phenyl)quinoline-8-sulfonamide-sulfate hydrate compound of formula (I).
IPC 分类号	A61K-031/4709 ; A61P-007/06 ; C07D-215/36
国家	印度
专业领域	医药卫生
语种	英语
成果类型	专利
文献类型	科技成果
条目标识符	http://119.78.100.226:8889/handle/3KE4DYBR/21224
专题	中国科学院新疆生态与地理研究所
作者单位	MAITHRI DRUGS PRIVATE LTD (MAIT-Non-standard)
推荐引用方式 GB/T 7714	LAKSHMI C V,PRADEEP R,RAMPRASAD A K,et al. New crystalline form-M of mitapivat sulfate for treating hemolytic anemia, is characterized by the powder X-ray Diffraction pattern having specific peaks. IN202341048804-A[P]. 2023.

条目包含的文件
条目无相关文件。

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。